News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CeNes Pharmaceuticals (U.S.) (CEN.L) Starts Recruitment for Phase II trial of CNS 5161 for Cancer Pain


9/12/2007 11:42:39 AM

LONDON (Thomson Financial) - CeNeS Pharmaceuticals PLC said it has started recruitment for a Phase II study of the potential new pain drug CNS 5161, which is being developed under a co-development deal with the ERGOMED Group.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES